ADEXUSDx® COVID-19 Test Receives Conformité Européene (CE) Mark Approval

SPRINGDALE, ARK. – July 28, 2020 – We are proud to announce that our ADEXUSDx COVID-19 antibody test has received Conformité Européene (CE) mark approval across 28 countries in the EU. With CE approval, our antibody test will be available in a variety of healthcare centers such as clinics and hospital emergency rooms.

Our ADEXUSDx COVID-19 Test is a rapid serology, self-contained assay that measures the presence of SARS-CoV-2 antibodies and delivers accurate and reliable results in 15 minutes with no buffers, reagents, or additional equipment.

Made in the USA, The ADEXUSDx® COVID-19 Test uses an FDA-cleared and CE-marked platform containing next-generation, easy-to-use technology that is affordable, portable, and delivers laboratory-quality results in minutes without any additional supplies.

Interested in learning more? You can read the full article here.

NOWDiagnostics, Inc., based in Springdale, Arkansas, is a leader in innovative diagnostics testing. Its ADEXUSDx® product line features a lab at your fingertip, using a single drop of blood to test for a variety of common conditions, illnesses, and diseases, with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics products have the potential to decrease the waiting period to determine test results by days. For more information about NOWDiagnostics, visit www.nowdx.com. For more information about the ADEXUSDx® COVID-19 Test, including its intended use, features, benefits and limitations, and directions for use, visit www.c19development.com. The ADEXUSDx® COVID-19 Test will be distributed by C19 Development, LLC, a wholly owned subsidiary of NOWDiagnostics. Laboratories may contact www.c19development.com/order to place an order.

Contacts

NOWDiagnostics Company Contact
Beth Cobb, Director of Operations
Email: beth.cobb@nowdx.com

NOWDiagnostics Media Contact
Claire Burghoff, CGA Group
Email: media@nowdx.com

Previous Article Next Article

Check out what is making the news

Find out the latest in diagnostics testing.

First and Only In-Home Test for Syphilis Now Available to Consumers through Major Retailers and Public Health: NOWDiagnostics Launches First To Know® Syphilis Test Across the U.S.

Todd Simpson

With syphilis cases on the rise, NOWDx’s over-the-counter test offers rapid, in-home results in minutes and is now available nationwide in thousands of pharmacies, retail, and drugstore locations and on Amazon SPRINGDALE, Ark. – November 19, 2024 – NOWDiagn...

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.

Todd Simpson

As syphilis cases surge nationwide, the collaboration will bring the First To Know® over-the-counter test to clinicians and patients across professional and hospital settingsSPRINGDALE, ARK. – October 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of ...

NOWDiagnostics First To Know® Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use

Todd Simpson

First and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announce...